Beech Hill Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,987
Closed -$633K 79
2017
Q4
$633K Buy
1,987
+517
+35% +$166K 0.31% 56
2017
Q3
$460K Buy
1,470
+300
+26% +$88.8K 0.24% 58
2017
Q2
$317K Sell
1,170
-95
-8% -$25.1K 0.17% 67
2017
Q1
$346K Sell
1,265
-849
-40% -$240K 0.2% 64
2016
Q4
$599K Buy
2,114
+30
+1% +$8.89K 0.36% 42
2016
Q3
$652K Buy
+2,084
New +$617K 0.4% 40
2016
Q2
Sell
-1,390
Closed -$362K 75
2016
Q1
$362K Sell
1,390
-786
-36% -$208K 0.28% 47
2015
Q4
$667K Buy
2,176
+120
+6% +$34.5K 0.42% 48
2015
Q3
$600K Sell
2,056
-247
-11% -$81.6K 0.38% 46
2015
Q2
$930K Buy
2,303
+270
+13% +$108K 0.48% 42
2015
Q1
$858K Buy
2,033
+76
+4% +$30K 0.4% 45
2014
Q4
$664K Sell
1,957
-458
-19% -$148K 0.33% 51
2014
Q3
$799K Buy
2,415
+430
+22% +$142K 0.38% 51
2014
Q2
$626K Sell
1,985
-511
-20% -$154K 0.28% 70
2014
Q1
$763K Buy
2,496
+321
+15% +$102K 0.36% 55
2013
Q4
$608K Buy
2,175
+400
+23% +$103K 0.31% 67
2013
Q3
$427K Buy
1,775
+475
+37% +$106K 0.23% 81
2013
Q2
$280K Buy
+1,300
New +$278K 0.16% 98

Other funds holding BIIB

Beech Hill Advisors's BIIB Position: Q1 2018 in Review

Beech Hill Advisors sold out of Biogen (BIIB) in Q1 2018, closing a stake of 1,987 shares — an estimated $633K sold.

Beech Hill Advisors first reported a position in BIIB in Q2 2013 and held it in 18 quarters. The position peaked at $930K in Q2 2015. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Beech Hill Advisors reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • Beech Hill Advisors sold 1,987 Biogen shares in Q1 2018, an estimated $633K.
  • Beech Hill Advisors first reported a position in Biogen in Q2 2013 and held it in 18 quarters.
  • Beech Hill Advisors's Biogen position peaked at $930K in Q2 2015.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Beech Hill Advisors's 13F filing for Q1 2018, filed 23 Apr 2018.